Spec. karta Evropejskoj Rossìi. 25 (11/40) / izd. Voen. top. upravl. General'n. Štaba ; pod" redakc. Strěl'bickago.

Masštab" v" Anglìjskom" dûjmě 10 russk. verst" ili 1:420000.

The effect of sun exposure on 25-hydroxyvitamin D concentrations in young healthy subjects living in the city of São Paulo, Brazil

The range of 25-hydroxyvitamin D (25OHD) concentration was determined in a young healthy population based on bone metabolism parameters and environmental and behavioral aspects. We studied 121 healthy young volunteers (49 men, 72 women) living in São Paulo (23º 34' south latitude) belonging to three occupational categories: indoor workers (N = 28), medical school students (N = 44), and resident physicians (N = 49). Fasting morning blood samples were collected once from each volunteer from August 2002 to February 2004, and 25OHD, total calcium, albumin, alkaline phosphatase, phosphorus, creatinine, intact parathyroid hormone, osteocalcin, and type I collagen carboxyterminal telopeptide were measured. Data are reported as means ± SD. Mean subject age was 24.7 ± 2.68 years and mean 25OHD level for the entire group was 78.7 ± 33.1 nM. 25OHD levels were lower (P < 0.05) among resident physicians (67.1 ± 27.0 nM) than among students (81.5 ± 35.8 nM) and workers (94.0 ± 32.6 nM), with the last two categories displaying no difference. Parathyroid hormone was higher (P < 0.05) and osteocalcin was lower (P < 0.05) among resident physicians compared to non-physicians. Solar exposure and frequency of beach outings showed a positive association with 25OHD (P < 0.001), and summer samples presented higher results than winter ones (97.8 ± 33.5 and 62.9 ± 23.5 nM, respectively). To define normal levels, parameters such as occupational activity, seasonality and habits related to solar exposure should be taken into account. Based on these data, we considered concentrations above 74.5 nM to be desired optimal 25OHD levels, which were obtained during the summer for 75% of the non-physicians.

Spec. karta Evropejskoj Rossìi. 40 (25/54) / [sostavlena pri Voenno-Topografičeskom" otděle Glavnago štaba v" 1865-1871 gg.] pod" redakcìej Strěl'bickago.

Masštab" v" Anglìjskom" dûjmě 10 russk. verst" ili 1:420000.

Euroopan keskuspankin ohjauskorkopäätösten vaikutus OMX Helsinki 25 indeksin muutoksiin

Tutkielmassa tarkastellaan Euroopan keskuspankin operoiman ohjauskoron toimintalogiikkaa, sekä miten ohjauskorkomuutokset ovat vaikuttaneet OMX Helsinki 25 indeksin tuottoihin vuosien 2004 ja 2014 välillä.

Meditationes sancti evangelii 25

Invokaatio: Deo duce.

Meditationes sanctarum epistolarum 25

Arkit: A-B4.

Synopsis theologiae 25

Invokaatio: In nomine Jesu!

De justificatione hominis peccatoris coram Deo, ad amussim aphorismi apostolici Rom: 3:24.25

Variantti B.

Chronicon episcoporum Finlandensium 25

Arkit: 1 arkintunnukseton lehti, 3C-3D4.

Dissfrtatio [!] philologica ... fidem Jobi ex cap. XIX:25, 26, 27. Considerans, qvam ex decrete celeberrimi consistorii Acad. Aboens. adprobante ampliss. facult. phil. publico bonorum examini sistit mag. Matthias Hallenius, facult. theol. adjunctus & pastor in Lundå, respondente Gabriele Tålpo, Aboensi, ad diem Deo volente, XXVII Julii, anni MDCCXLI. In auditorio maximo, horis ante meridiem solitis

Invokaatio: In nomine Jesu!

Serum 25-hydroxyvitamin D and biochemical markers of bone metabolism in patients with juvenile idiopathic arthritis

Our objective was to evaluate the concentrations of serum 25-hydroxyvitamin D [25(OH)D], serum calcium, serum phosphorus, alkaline phosphatase, and parathormone (PTH) in patients with polyarticular juvenile idiopathic arthritis (JIA) and to associate them with disease duration and activity, bone mineral density and use of medications. In a cross-sectional and controlled study, 30 patients with polyarticular JIA were evaluated and compared to 30 healthy individuals matched for age and gender. Clinical status, anthropometry, laboratory markers in both patients and controls, and bone mineral density, only in the patients, were measured. Of the 30 patients included in the study, 23 (76.7%) were female and 16 (53.3%) non-Caucasian; mean age was 14 years (range = 4 to 20 years). Mean disease duration was 5 years (range = 1 to 12 years). The mean concentrations of serum albumin-corrected calcium (9.04 ± 0.41 mg/dL) and alkaline phosphatase (153.3 ± 100.1 IU) were significantly lower in patients with JIA than in controls (P < 0.0001 and P = 0.001, respectively). No differences in 25(OH)D, PTH or serum phosphorus were observed between JIA and control subjects. Regarding 25(OH)D concentration, 8 patients (26.7%) and 5 controls (16.7%) had 25(OH)D concentrations compatible with deficiency (lower than 20 ng/mL) and 14 patients (46.7%) and 18 controls (60%) had concentrations compatible with insufficiency (20-32 ng/mL). These values were not associated with disease activity, use of medications or bone mineral density. We observed a high frequency of 25(OH)D insufficiency and deficiency in the study sample. The compromised bone metabolism emphasizes the importance of follow-up of JIA patients.

Low serum concentrations of 25-hydroxyvitamin D in children and adolescents with systemic lupus erythematosus

We evaluated the concentrations of 25-hydroxyvitamin D [25(OH)D] in children and adolescents with juvenile systemic lupus erythematosus (JSLE) and associated them with disease duration and activity, use of medication (chloroquine and glucocorticoids), vitamin D intake, calcium and alkaline phosphatase levels, and bone mineral density. Thirty patients with JSLE were evaluated and compared to 30 healthy individuals, who were age and gender matched. Assessment was performed of clinical status, disease activity, anthropometry, laboratory markers, and bone mineral density. The 30 patients included 25 (83.3%) females and 16 (53.3%) Caucasians, with a mean age of 13.7 years. The mean age at diagnosis was 10.5 years and mean disease duration was 3.4 years. Mean levels of calcium, albumin, and alkaline phosphatase were significantly lower in patients with JSLE compared with controls (P<0.001, P=0.006, and P<0.001, respectively). Twenty-nine patients (97%) and 23 controls (77%) had 25(OH)D concentrations lower than 32 ng/mL, with significant differences between them (P<0.001). Fifteen patients (50%) had vitamin D levels <20 ng/mL and 14 had vitamin D levels between 20 and 32 ng/mL. However, these values were not associated with greater disease activity, higher levels of parathormone, medication intake, or bone mineral density. Vitamin D concentrations were similar with regard to ethnic group, body mass index, height for age, and pubertal stage. Significantly more frequently than in controls, we observed insufficient serum concentrations of 25(OH)D in patients with JSLE; however, we did not observe any association with disease activity, higher levels of parathormone, lower levels of alkaline phosphatase, use of medications, or bone mineral density alterations.

Treatment with 1,25(OH)2D3induced HDAC2 expression and reduced NF-κB p65 expression in a rat model of OVA-induced asthma

Recent evidence indicates that a deficiency of 1,25-dihydroxyvitamin D3 (1,25[OH]2D3) may influence asthma pathogenesis; however, its roles in regulating specific molecular transcription mechanisms remain unclear. We aimed to investigate the effect of 1,25(OH)2D3 on the expression and enzyme activity of histone deacetylase 2 (HDAC2) and its synergistic effects with dexamethasone (Dx) in the inhibition of inflammatory cytokine secretion in a rat asthma model. Healthy Wistar rats were randomly divided into 6 groups: control, asthma, 1,25(OH)2D3 pretreatment, 1,25(OH)2D3 treatment, Dx treatment, and Dx and 1,25(OH)2D3 treatment. Pulmonary inflammation was induced by ovalbumin (OVA) sensitization and challenge (OVA/OVA). Inflammatory cells and cytokines in the bronchoalveolar lavage (BAL) fluid and histological changes in lung tissue were examined. Nuclear factor kappa B (NF-κB) p65 and HDAC2 expression levels were assessed with Western blot analyses and quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR). Enzyme activity measurements and immunohistochemical detection of HDAC2 were also performed. Our data demonstrated that 1,25(OH)2D3 reduced the airway inflammatory response and the level of inflammatory cytokines in BAL. Although NF-κB p65 expression was attenuated in the pretreatment and treatment groups, the expression and enzyme activity of HDAC2 were increased. In addition, 1,25(OH)2D3 and Dx had synergistic effects on the suppression of total cell infusion, cytokine release, and NF-κB p65 expression, and they also increased HDAC2 expression and activity in OVA/OVA rats. Collectively, our results indicated that 1,25(OH)2D3might be useful as a novel HDAC2 activator in the treatment of asthma.

Colesterol, 7-cetocolesterol e 25-hidroxicolesterol em maionese

A maionese é um alimento com predominância lipídica característica. O sistema antioxidante artificial usado resulta em longa vida-de-prateleira do produto. Mas não existem conhecimentos suficientes quanto à estabilidade oxidativa do colesterol incorporado à maionese, através do ovo. Neste trabalho foi confirmada a oxidação do colesterol contido na maionese, pela presença do 7-Cetocolesterol (7-Ceto),1,99±0,59µg/g, em amostras recém-fabricadas (~15 dias), de 7-Ceto, 8,30±4,03 a 22,86±3,06µg/g, e de 25-Hidroxicolesterol, 2,21±1,94 a 13,98±2,72µg/g, em amostras comerciais (A,B,C,D e E) com tempos de fabricação de 30 a 210 dias, e de 7-Ceto, 8,44±6,78µg/g, em amostras coletadas em domicílios (produto em uso, mantido em geladeira), quantificados por HPLC. O somatório dos óxidos de colesterol (OsC) analisados nas amostras A/E correspondeu a 2,07-4,94% em relação ao colesterol (50,66±3,08-73,36±3,53mg/100g). Os resultados obtidos são significativos em relação às atividades biológicas deletérias atribuídas aos OsC, e quanto ao aspecto tecnológico envolvido na produção da maionese.